| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/15/2004 | EP1455793A2 Antidiabetic formulation and method |
| 09/15/2004 | EP1455791A1 Method for administering birb 796 bs |
| 09/15/2004 | EP1455785A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 09/15/2004 | EP1455778A2 Methods for the treatment of peripheral neural and vascular ailments |
| 09/15/2004 | EP1455774A1 Pharmaceutical composition for treating obesity |
| 09/15/2004 | EP1455765A2 Use of protease-activated receptor-2 inhibitor in the manufacture of a medicament for treating delayed hypersensitivity |
| 09/15/2004 | EP1455605A1 Soft drink replacer |
| 09/15/2004 | EP1455602A1 Modified methionine rich food products and process for their manufacture |
| 09/15/2004 | EP1455601A1 Composition for promotion of bone growth and maintenance of bone health |
| 09/15/2004 | EP1455588A1 Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis |
| 09/15/2004 | EP1363902B1 Chemical compounds |
| 09/15/2004 | EP1294881B1 Control of metabolism with compositions of the human 2-oxoglutarate carrier |
| 09/15/2004 | EP1246638B1 Use of exendins and agonists thereof for the treatment of hypertriglyceridemia |
| 09/15/2004 | EP1212317B1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 09/15/2004 | EP1173440B1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands |
| 09/15/2004 | EP1133467B1 Ion channel modulating agents |
| 09/15/2004 | EP1077925B1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 09/15/2004 | EP1073467B1 Co-solvent formulations comprising a vitamin d compound |
| 09/15/2004 | EP1056359B1 Product and method to reduce stress induced immune suppression |
| 09/15/2004 | EP1054669B9 Use of thiadiazolo[4,3-a]pyridine derivatives |
| 09/15/2004 | EP0981282B1 Process for preparing a nutritional supplement and nutritional supplement |
| 09/15/2004 | EP0889726B1 Novel cycloalkyl substituted imidazoles |
| 09/15/2004 | EP0877760B1 Mhc complexes and uses thereof |
| 09/15/2004 | EP0714404B1 Anti-inflammatory peptides |
| 09/15/2004 | EP0671910B1 Use of adamantane derivatives for the manufacture of a medicament in the TREATMENT of glaucoma |
| 09/15/2004 | EP0656786B1 Use of isoflavone phyto-oestrogen extracts of soy or clover |
| 09/15/2004 | CN1529757A Fusion Protein for secretion of protein of interest in supernatant of bacterial culture |
| 09/15/2004 | CN1529706A 哌嗪衍生物 Piperazine derivatives |
| 09/15/2004 | CN1529704A 3-(4-amidopyrrol-2-2ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors |
| 09/15/2004 | CN1529698A Taiazole or oxazole derivatives which are useful in treatment of cardiovascular and related diseases |
| 09/15/2004 | CN1529697A Tricyclic compounds useful as angiotensin II agonists |
| 09/15/2004 | CN1529617A Method for treaing autoimmune diseases in subject and in vitro diagnostic assays |
| 09/15/2004 | CN1529613A Method for using nervous thread proteins to treat tumors and other conditions requiring removal of destruction of cells |
| 09/15/2004 | CN1529603A Use of bile acid or bile salt fatty acid conjugates |
| 09/15/2004 | CN1529599A Acylic piperazine and piperidine derivatives which are used for treating neuronal damage |
| 09/15/2004 | CN1529598A Method of treating demyelinating diseases or conditions |
| 09/15/2004 | CN1529595A 4,5-hydro-1H-pyrazole derivative having protent CB1-antagonistic |
| 09/15/2004 | CN1529592A Body fat level controllers |
| 09/15/2004 | CN1529590A Compositions and methods to treat neovascularization and disease associated with thereof |
| 09/15/2004 | CN1528790A Unsaturated fatty acid modified insulin and preparing method thereof |
| 09/15/2004 | CN1528789A Alpha-lipoic acid and its derivative modified insulin and preparing method thereof |
| 09/15/2004 | CN1528788A Cholalic acid derivative medified insulin and preparing method thereof |
| 09/15/2004 | CN1528753A Morpholol with medicinal activity |
| 09/15/2004 | CN1528723A Technological method for extracting active principle of dragon's blood by supercritical fluid |
| 09/15/2004 | CN1528449A Spirulina soft capsule and preparing method thereof |
| 09/15/2004 | CN1528448A Medicine with blood fat regulating function |
| 09/15/2004 | CN1528447A Medicine for treating diabets mellitus and preparing process thereof |
| 09/15/2004 | CN1528444A Capsule for reducing hyperlipemia |
| 09/15/2004 | CN1528407A Composition for preventing and treating diabets mellitus |
| 09/15/2004 | CN1528395A Fatty-reducing paster |
| 09/15/2004 | CN1528394A Weight-reducing paster |
| 09/15/2004 | CN1528385A Chinese medicine resina draconis extract preparing method |
| 09/15/2004 | CN1528347A Nano-level pearl powder-conch powder biological calcium tablet |
| 09/15/2004 | CN1528339A Chitin soft capsule and preparing method thereof |
| 09/15/2004 | CN1528319A Gynostemma pentaphylla total aglycone drop pill and preparing method thereof |
| 09/15/2004 | CN1528292A Simvastatin drop pill and preparing method thereof |
| 09/15/2004 | CN1528291A Lovastatin drop pill and preparing method thereof |
| 09/15/2004 | CN1528279A Organic bio-iodine and its use |
| 09/15/2004 | CN1528264A Black mud for producing beauty, thinning and skin-care articles |
| 09/15/2004 | CN1528195A Kudzu vine root series health-care product and preparing method thereof |
| 09/15/2004 | CN1166678C Purine derivatives |
| 09/15/2004 | CN1166667C Imidazoimidazoles and trizoles as anti-inflammatory agents |
| 09/15/2004 | CN1166666C Fused imiazole compounds and remedies for diabetes mellitus |
| 09/15/2004 | CN1166659C Novel hetero naphthenic benzcyclobutane and heterocyclo acryl benzcyclobutane compound, their prepn. method and pharmaceutical composites |
| 09/15/2004 | CN1166654C Benzoylguanidine derivatives wit advantageous properties, method for producing them and their use in production of medicaments |
| 09/15/2004 | CN1166633C New alpha-amino acid sulfuryl compounds, its preparing method and medicinal composition containing them |
| 09/15/2004 | CN1166382C Chinese herb. medicine composition for treating diabetes and nephropathy and its preparing method |
| 09/15/2004 | CN1166365C Alendronic-acid medicind composition and use of same for preparing medictne for inhibiting bone resorption of humanbody |
| 09/14/2004 | US6790984 Process for purifying pravastatin sodium from a fermentation broth |
| 09/14/2004 | US6790953 Ether compounds |
| 09/14/2004 | US6790860 Pyrrolidine derivatives |
| 09/14/2004 | US6790848 4-piperazinylindole derivatives with 5-HT6 receptor affinity |
| 09/14/2004 | US6790656 Galanin receptors (galr2); involved in various neurological and neurodegenerative disorders and treatments |
| 09/14/2004 | US6790649 Phex gene (phosphate regulating gene with homologies to endopeptidases on x chromosome); for treatment of x-linked hypophosphatemia (xlh), a phosphate homeostasis disorder; retardation, bone, renal and metabolism disorders |
| 09/14/2004 | US6790639 Bone morphogenic proteins; for regulating bone homeostasis, adiposity, and calcification of atherosclerotic plaques |
| 09/14/2004 | US6790450 Use of coxiella bacteria to treat autoimmune disease |
| 09/14/2004 | US6790443 Administering to the subject a therapeutically effective amount of an agent which inhibits binding of advanced glycation endproducts to any receptor for advanced glycation endproducts |
| 09/14/2004 | CA2280708C Cetp activity inhibitors |
| 09/11/2004 | CA2458288A1 Method and compound to reduce the incidence of diabetes in a subject with chronic heart failure |
| 09/10/2004 | WO2004076657A2 Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides |
| 09/10/2004 | WO2004076458A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 09/10/2004 | WO2004076447A1 Cycloalkyl derivatives comprising bioisosteric carboxylic acid groups, method for the production thereof, and use thereof as a medicament |
| 09/10/2004 | WO2004076441A1 Process for producing acid adduct salt of polyacidic base compound |
| 09/10/2004 | WO2004076437A1 Benzopyran compounds, process for preparing the same and their use |
| 09/10/2004 | WO2004076430A1 Benzothiazepine and benzothiepine derivatives |
| 09/10/2004 | WO2004076428A1 4-(3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexyloxy)-butane acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis |
| 09/10/2004 | WO2004076427A1 3-(2-phenyl-oxazol-4-yl methoxy) cyclohexylmethoxy acetic acid derivatives and related compounds used as ppar modulators for treating type 2 diabetes and arteriosclerosis |
| 09/10/2004 | WO2004076426A1 3-methyl-2- (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexanecarbonyl-amino butyric acid derivatives and related compounds as ppar modulators for the treatment of type 2 diabetes and atherosclerosis |
| 09/10/2004 | WO2004076420A1 Heteroarylcarbamoylbenzene derivative |
| 09/10/2004 | WO2004076413A2 Phenyl- and pyridylpiperidine-derivatives as modulators of glucose metabolism |
| 09/10/2004 | WO2004076401A1 Cycloalkyl-substituted alkanoic acid derivatives, methods for the production thereof, and use thereof as a medicament |
| 09/10/2004 | WO2004075891A1 1,3-substituted cycloalkyl derivatives containing acidic, mainly heterocyclic groups, corresponding production method and use of said derivatives as medicaments |
| 09/10/2004 | WO2004075823A2 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 09/10/2004 | WO2004075815A2 Diarylcycloalkyl derivatives, method for their production and their use as medicaments |
| 09/10/2004 | WO2004052847A3 Tricyclic steroid hormone nuclear receptor modulators |
| 09/10/2004 | WO2004014352A3 Methods for treating carbonic anhydrase mediated disorders |
| 09/10/2004 | WO2003090671A3 Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance |
| 09/10/2004 | WO2003053169A8 Soft drink replacer |
| 09/10/2004 | WO2003003979A3 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 09/10/2004 | WO2002094780A3 Kinases and phosphatases |